Ventricular remodeling and the renin angiotensin aldosterone system

Congestive Heart Failure

Volumn 6, Issue 4, 2000, Pages 187-192

  Konstam, M A ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN;

DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART VENTRICLE REMODELING; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TREATMENT OUTCOME;

EID: 0034426462     PISSN: 10797998     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Ventricular remodeling and its prevention in the treatment of heart failure
2. Role of angiotensin converting enzyme inhibitors in preventing left ventricular remodeling following myocardial infarction
3. Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long term therapy with angiotensin converting enzyme inhibitor
4. The kallikrein-kinin system in post myocardial infarction cardiac remodeling
5. Aldosterone and spironolactone in heart failure
6. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
7. Left ventricular remodeling after myocardial infarction: A corollary to infarct expansion
8. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction
9. Which patients benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one year serial echocardiographic follow up from the Captopril And Thrombolysis Study (CATS)
10. Nonparallel changes in global left ventricular chamber volume and muscle mass during the first year after transmural myocardial infarction in humans
11. Patterns of left ventricular dilation during the six months after myocardial infarction
12. Left ventricular remodeling in the year after first anterior myocardial infarction: A quantitative analysis of contractile segment lengths and ventricular shape
13. Structural basis of end stage heart failure in ischemic cardiomyopathy in humans
14. Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy
15. Enhanced deposition of predominantly type I collagen in myocardial disease
16. Effects of the angiotensin converting enzyme inhibitor, enalapril, on the long term progression of left ventricular dysfunction in patients with heart failure
17. Effects of the angiotensin converting enzyme inhibitor, enalapril, on the long term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction
18. Ventricular enlargement and reduced survival after myocardial infarction
19. Left ventricular end systolic volume as the major determinant of survival after recovery from myocardial infarction
20. Variables predictive of survival in patients with coronary artery disease: Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic and quantitative angiographic evaluations
21. Myocardial infarct size and ventricular function in rats
22. Survival after an experimental myocardial infarction: Beneficial effects of long term therapy with captopril
23. Influence of chronic captopril on the infarcted left ventricle of the rat
24. Tissue specific activation of cardiac angiotensin converting enzyme in experimental heart failure
25. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes
26. 1 receptor subtype
27. Divergent effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats
28. Modulation of the renin angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing induced heart failure: II. Effects on myocyte contractile processes
29. Quantitative two dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction, the protective effect of captopril
30. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting enzyme inhibition
31. Randomized trial of losartan versus captopril in patents over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
32. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: Results of the ELITE ventricular function substudy
33. Angiotensin II and aldosterone regulation
34. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin 11 and aldosterone
35. Mineralocorticoids, hypertension, and cardiac fibrosis
36. Angiotensin II and collagen synthesis in cultured adult rat cardiac fibroblasts
37. Activation of cardiac aldosterone production in rat myocardial infarction: Effect of angiotensin II receptor blockade and role in cardiac fibrosis